Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 11/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | CYP8B1 | Q9UNU6 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31454781 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL3949948 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL8812022 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL300482 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL2346412 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL17777817 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL7989762 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL8574154 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL3955770 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 | |
| SCHEMBL29858099 | 1.00 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9617241-B2 | Intermediate compounds and process for the preparation of efinaconazole | MAPI PHARMA LTD. (IL) | 2017-04-11 | — | — | US | claimed |
| US-20160355500-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | MAPI PHARMA LTD. (IL) | 2016-12-08 | — | — | US | claimed |
| WO-2016079728-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | MAPI PHARMA LTD. (IL) | 2016-05-26 | — | — | WO | claimed |
| WO-2024258316-A1 | NOVEL POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND A TRIAZOLE | Общество с ограниченной ответственностью "Л-Био" | 2024-12-19 | — | — | WO | disclosed |
| CN-117756783-A | Preparation method of difluprednate | 浙江东亚药业股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-110997646-B | Process for producing epoxy alcohol compound | 住友化学株式会社 | 2023-06-20 | — | — | CN | disclosed |
| CN-113929660-B | Ring opening method of ethylene oxide derivative | 深圳市海滨制药有限公司 | 2022-10-04 | — | — | CN | disclosed |
| EP-3666762-B1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2022-04-06 | — | — | EP | disclosed |
| US-10730861-B2 | Process for producing epoxy alcohol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-08-04 | — | — | US | disclosed |
| EP-3666762-A1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172520-A1 | PROCESS FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-06-04 | — | — | US | disclosed |
| EP-0698606-A1 | AZOLYLAMINE DERIVATIVE | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1996-02-28 | — | — | EP | disclosed |
| US-5489606-A | FUNGICIDES, HUMAN, VETERNARY MEDICINE | SANKYO COMPANY, LIMITED (JP) | 1996-02-06 | — | — | US | disclosed |
| WO-1995025107-A1 | TRIAZOLE COMPOUNDS AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 1995-09-21 | — | — | WO | disclosed |
| US-5405861-A | Fungicides | TAKEDA CHEMICAL INDUSTRIES, CO., LTD. (JP) | 1995-04-11 | — | — | US | disclosed |
| US-5393769-A | Thio-, sulfinyl- or sulfonyl-substituted | SANKYO COMPANY, LIMITED (JP) | 1995-02-28 | — | — | US | disclosed |
| US-5387599-A | Fungicide | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-02-07 | — | — | US | disclosed |
| EP-0446877-A2 | Triazoles, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-09-18 | — | — | EP | disclosed |
| EP-0421210-A2 | Triazole compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-04-10 | — | — | EP | disclosed |
| EP-0322800-A1 | Process for preparation of sulfone derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1989-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172520-A1 | PROCESS FOR PRODUCING EPOXY ALCOHOL COMPOUND | ERG28, CYP2E1, ADH5 | CYP3A4 32/4885CYP2C9 108/4885CYP2C19 282/4885 |
| US-10730861-B2 | Process for producing epoxy alcohol compound | ERG28, CYP2E1, ADH5 | CYP3A4 32/4885CYP2C9 108/4885CYP2C19 282/4885 |
| US-20160355500-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | CYP2E1, CYP3A4, CYP4B1 | CYP3A4 2/4885CYP2C9 41/4885CYP2C19 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.